Postpartum-Plus-Perimenopause: The Collision the System Isn't Set Up For

TL;DR

• The average age at first birth is now 31.1 years across the OECD, and above 32 in Japan, Korea, Ireland, Italy, Spain and Switzerland. In the US it rose another 1.9% in the last twelve months.
• Perimenopause — the hormonal transition into menopause — can begin as early as 35, and typically lasts 4–10 years.
• For a growing cohort of women having babies in their late 30s and 40s, postpartum and perimenopause are running simultaneously. Same low-estrogen biology, doubled.
• A Washington Post feature published on 5 July 2026 named the phenomenon in the mainstream — building on a 2024 TikTok "old moms" trend that pushed past 2 million views and a growing clinical literature.
• The medical infrastructure is built around two separate patient journeys: obstetric care up to ~12 months postpartum, menopause care from ~45. The overlap belongs to neither. Most women in it are told their symptoms are "just postpartum" — until they aren't.

The number that reframes the story

In 1970, the average OECD mother had her first child in her early twenties. In 2024 she was 31.1. In Korea, 33.1. In Chile, still 27.1 — a reminder that this is a rich-country demographic story, not a universal one, though India and China are trending the same way in urban cohorts.

Perimenopause can begin at 35. It reliably arrives by the mid-40s. The math is not subtle: a meaningful and growing share of first-time mothers in wealthy economies are becoming mothers inside the hormonal transition into menopause, not before it.

This is not a story about a new condition. It is a story about an old one — two, actually, sitting on top of each other — finally meeting a demographic that makes it common enough to name.

What actually happened this week

On 5 July 2026, the Washington Post published a feature-length piece — "Postpartum or perimenopausal? For more women than ever, the answer is both" — that gave the collision a public name. It profiled women in their 40s and mid-40s describing symptoms that neither their OBs nor their GPs quite knew where to place: brain fog that outlasted the postpartum year, mood swings that got worse rather than better after weaning, night sweats that read as "hormonal" but resisted the standard scripts.

The piece did not break new science. It broke the framing. Clinical writing on the overlap has been accumulating since at least 2024 — TāraMD's "Is it Postpartum, Perimenopause, or Both?", the Alliance Center's clinical guide, Dr Suzanne Gilberg-Lenz's protocol work, Dr Sarah Hill's The Period Brain — and TikTok's "old moms" content has been building the vernacular in parallel. What shifted was that a top-tier US paper put it on a Sunday front-of-section with the medical framing intact.

That matters because it changes the sentence a woman can say in a clinic. "I might be in both at once" now lands as a recognisable clinical question, not a self-diagnosis.

The biology, in one paragraph

Both states are, at their core, low-estrogen states. In postpartum, estrogen and progesterone crash within 24 hours of placental delivery to levels comparable to a menopausal woman; if you are breastfeeding, prolactin holds them there. In late perimenopause, declining ovarian reserve produces the same low-hormone landscape, less abruptly but more durably. Progesterone — the body's endogenous mood stabiliser — falls faster than estrogen in both, which is why the mood profile of the overlap is so specific: not just low, but flat, wired, and forgetful in the same week. There is also emerging recognition of genitourinary syndrome of lactation — the breastfeeding analogue of the well-known genitourinary syndrome of menopause — and evidence that women who deliver after 35 have measurably higher rates of postpartum depression, and that perimenopausal women are roughly twice as likely to experience clinical depression as premenopausal peers. Stack those risk profiles and the mental-health picture stops being a curiosity.

Why the medical system misses it

Three structural reasons, none of them anyone's fault individually:

1. The care windows don't overlap on paper. In most systems — the NHS, Australia's Medicare, most European public systems, and US private insurance — postpartum care is time-boxed. Six weeks of active follow-up, twelve months of loose obstetric horizon. Menopause care is age-boxed: taken seriously somewhere in the mid-40s, often later. A 42-year-old at six months postpartum sits inside the postpartum window and outside the menopause one. Her clinician is not wrong to attribute symptoms to the recent birth. She is often just not looking further.

2. The symptom overlap is near-total. Fatigue. Sleep disruption. Anxiety. Depression. Brain fog. Mood swings. Irregular cycles. Night sweats. Vaginal dryness. Low libido. Every item on the postpartum checklist is also on the perimenopause checklist. Prolactin from breastfeeding suppresses ovulation, so the most useful diagnostic signal — cycle behaviour — is unavailable while nursing. The overlap is the diagnostic problem.

3. Nobody owns the patient. Obstetrics discharges her; the GP triages against acute complaints; the menopause specialist — where such a specialist exists in the local system at all — considers her too young. In Australia, where GP-led women's health is comparatively strong, the picture is better than in the US private system but still patchy. The UK's rollout of NHS Menopause Hubs began in 2024; access remains uneven and postpartum women are not a defined referral pathway.

The result, repeated across enough clinics to be a pattern rather than an anecdote: a 41-year-old at nine months postpartum, still exhausted, told confidently that "it'll settle" — and it doesn't, because half of what she is experiencing is not going to.

What's genuinely new — and what isn't

New: The clinical vocabulary is finally consolidating. Genitourinary syndrome of lactation is beginning to appear in the same textbooks that carry its menopausal counterpart. Certified Menopause Practitioner training (via the Menopause Society, formerly NAMS) has begun including a postpartum overlap module. A defensible symptom-tracking framework — cycle + mood + energy + sleep + vasomotor — is emerging as the practical instrument for telling the two apart, or catching the moment one becomes the other. Hormone Replacement Therapy protocols now have careful guidance for the specific case of the perimenopausal woman who is postpartum and non-lactating.

Not new: The underlying biology has not changed. Women having children in their late thirties and forties is not a new phenomenon in absolute terms — Sarah in Genesis, Marmee in Little Women, aunts in most extended families — but it is newly common enough to matter at the population level. There is also no evidence that pregnancy accelerates the onset of perimenopause. The two are running in parallel because the reproductive window has stretched into the transitional one, not because childbirth is triggering anything.

Also not new, and worth flagging: the framing risks obscuring that this is a rich-country story. Global average age at first birth is still 24.5. In much of sub-Saharan Africa, South Asia, and Latin America, the collision is rare because first births are earlier. That doesn't diminish the story — it locates it.

Who is actually in this

Roughly four groups, in order of directness:

• Women currently postpartum, aged 38–47. The direct population. In OECD countries with mean first-birth ages above 32 — Korea, Japan, Ireland, Italy, Spain, Switzerland — a large share of first-time mothers now fall into this window.
• Women planning first or second pregnancies in their late 30s and 40s. Perimenopausal changes may already be underway before conception; symptom baselines pre-pregnancy are diagnostically useful and rarely captured.
• Clinicians in three specialties who don't currently coordinate: obstetrics/midwifery, general practice/family medicine, and menopause/gynaecology. The overlap is exactly where their referral graphs go quiet.
• Partners and immediate family. Because the mental-health load of the overlap is real, and the "she's just postpartum" script is often wielded by the household, not just the clinic.

Who benefits from the noise

Two constituencies get a tailwind from this framing being in the Washington Post, and it's worth being clear-eyed about both.

The first is legitimate: menopause specialists, perinatal mental health clinicians, and integrative women's-health practices who have been quietly documenting this overlap for a decade. Recognition raises their referral density and their bargaining position with insurers.

The second is the wellness-industrial complex — supplement lines, hormone-testing services, direct-to-consumer HRT and compounded hormone platforms — which will meet the moment with hormone panels of variable clinical utility and protocols of variable evidence. The specific weakness to watch: at-home hormone panels sold to postpartum women without a menopause-trained clinician interpreting them. Prolactin from breastfeeding distorts every reading. A single-day estradiol snapshot in a woman with fluctuating perimenopausal hormones is close to meaningless. Any protocol built on that data will be, at best, harmless and expensive.

The framing is real. The bandwagon will be uneven.

What to do — for the natural audience of this story

(Addressed to women in or approaching the overlap, and to their partners and clinicians. Not to any organisation.)

If you are postpartum and 38+:

• Track five variables daily for at least eight weeks, not just mood: cycle (or breastfeeding status), sleep quality, energy, mood, and vasomotor symptoms (hot flashes, night sweats). A phone note or a menstrual-tracking app with symptom fields is enough. This is the single most useful thing you can bring to a clinician.
• Ask specifically for a Certified Menopause Practitioner (in the US, via menopause.org's practitioner directory; in Australia, via the Australasian Menopause Society; in the UK, via the British Menopause Society). Not every GP or OB has this training; those who do have it are visibly listed.
• Request a baseline panel if you have finished breastfeeding or are formula-feeding: FSH, LH, estradiol, progesterone, AMH, TSH/free T4, ferritin, vitamin D, B12, and omega-3 index. Interpret with someone who understands both postpartum recovery and ovarian aging. Do not run this panel while actively breastfeeding — prolactin will corrupt the estradiol/progesterone reading and you will pay for information you cannot use.
• If you are considering HRT, do it inside a clinician relationship, not a DTC portal. The specific case of the postpartum, non-lactating, perimenopausal woman has protocol nuances that a menopause-trained clinician will handle carefully and a subscription service typically will not.
• Screen for depression on the EPDS at 6, 9, and 12 months postpartum, not just once at the standard 6-week visit. The postpartum-plus-perimenopause depression risk stack is higher, and the standard screening cadence was designed for a younger cohort.

If you are planning pregnancy at 38+:

• Ask for the same panel before trying. A pre-pregnancy hormonal baseline is the most useful data point you will not otherwise get.
• Have the conversation about perimenopausal onset before conception. Many women discover in the postpartum year that symptoms they had attributed to age or stress were early perimenopause; naming that in advance makes the postpartum experience legible.

If you are a partner or close family member:

• The "she's just postpartum" script is often deployed with kindness and is often wrong at this age band. If symptoms are persisting past nine months, worsening after weaning, or including hot flashes or vasomotor symptoms, that is signal, not baseline.

If you are a clinician:

• Add an age-band flag to your postpartum protocol at 38 and 40. At the 6-month or 9-month visit for these patients, run the overlap screen explicitly. The current default of attributing everything to postpartum recovery is the most common failure mode in the literature.

Where the honest answer is: there may be nothing to do beyond recognition, name that too. For a woman at 43, nine months postpartum, still breastfeeding, exhausted, the immediate diagnostic move may be to wait until weaning to get a clean read. Recognition without over-medicalising is the win.

Uncertainty ledger

• Prevalence is not well-measured. We know the demographic drivers are real; we do not have clean prevalence data on how many women are clinically symptomatic in the overlap versus asymptomatic. Registry work is beginning; results are years away.
• HRT during the postpartum-perimenopause overlap is under-studied. The general safety data for HRT in perimenopause is robust; the specific case of the recently-postpartum woman is thinner. Clinicians are extrapolating carefully. Watch this literature.
• Cultural mediation is unclear. How much of the reported experience is biology and how much is the specific demand structure of parenting in one's 40s (careers, older parents, less peer support) is not disaggregated in most of the current discourse. Both are real; the proportions matter for what actually helps.
• What would change the analysis: a large, prospective cohort study of first-time mothers 38+ tracking hormonal and mental-health trajectories to 24 months postpartum. Nothing at that scale is published yet.

Bottom line

The average first-time mother in most wealthy countries is now old enough that her postpartum crash and her perimenopause are, in hormonal terms, the same low-estrogen event. The medical system still treats them as two — with different specialists, different windows, and no referral pathway between them. If you are in this cohort, or you love someone who is, the most useful move right now is not a supplement, a hormone panel, or a wellness protocol. It is a sentence you can bring to a clinician: I might be in both at once. That sentence is, for the first time this week, one that a doctor can be expected to recognise.

Sources

• Washington Post — "Postpartum or perimenopausal? For more women than ever, the answer is both", 5 July 2026 (Tier 1)
• OECD Family Database SF2.3 — Age of mothers at childbirth and age-specific fertility, 2024 data, updated June 2026 (Tier 1)
• Our World in Data — Average age of mothers at childbirth, updated October 2025 (Tier 1)
• Parents.com — "Is It Postpartum Or Perimenopause? How To Tell the Difference", featuring Dr Sarah E. Hill (TCU) and Dr Lauren Tetenbaum, October 2025 (Tier 2)
• Wenatal clinical Q&A with Dr Suzanne Gilberg-Lenz, September 2025 (Tier 2)
• TāraMD — "Is it Postpartum, Perimenopause, or Both?", June 2026 (Tier 2)
• The Alliance Center CT — "The Intersection of Postpartum & Perimenopause" clinical guide, 2024 (Tier 2)
• Washington Parent / Dr Emma Basch & Associates — "Perimenopause & Moms' Mental Health", May 2025 (Tier 3)
• Mother.ly — coverage of the "old moms" TikTok trend (2M+ views), Brazell/Victor, 2024 (Tier 3)